1. Home
  2. CGEM vs ARRY Comparison

CGEM vs ARRY Comparison

Compare CGEM & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.31

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$9.27

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
ARRY
Founded
2016
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
1.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CGEM
ARRY
Price
$10.31
$9.27
Analyst Decision
Strong Buy
Buy
Analyst Count
8
20
Target Price
$28.00
$10.38
AVG Volume (30 Days)
1.2M
5.5M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,333,329,000.00
Revenue This Year
N/A
$40.97
Revenue Next Year
N/A
$13.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.75
52 Week Low
$5.68
$3.76
52 Week High
$13.33
$10.47

Technical Indicators

Market Signals
Indicator
CGEM
ARRY
Relative Strength Index (RSI) 50.85 54.54
Support Level $9.48 $8.30
Resistance Level $10.42 $10.29
Average True Range (ATR) 0.71 0.53
MACD -0.17 0.05
Stochastic Oscillator 23.48 45.31

Price Performance

Historical Comparison
CGEM
ARRY

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: